Analyzing Stock On Your Own: Pacira BioSciences Inc (NASDAQ: PCRX)

Pacira BioSciences Inc (NASDAQ:PCRX) does about 909.81K shares in volume on a normal day but saw 1190883 shares change hands in Friday trading. The company now has a market cap of 980.34M USD. Its current market price is $21.06, marking a decrease of -2.77% compared to the previous close of $21.66. The 52 week high reached by this stock is $40.16 whilst the lowest price level in 52 weeks is $20.52.

Pacira BioSciences Inc (PCRX) has a 20-day trading average at $27.42 and the current price is -47.56% off the 52-week high compared with 2.63% distance from its 52-week low. The 50-day simple moving average of the closing price is $28.39 and its 200-day simple moving average is $29.49. If we look at the stock’s price movements over the week, volatility stands at 11.11%, which decreases to 5.50% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 22.28 to suggest the stock is oversold.

The consensus objective for the share price is $42.11, suggesting that the stock has a potential upside of 49.99% over the period.


The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 03, 2024 when Barclays downgraded the stock to “Equal Weight” and issued a price target of between $38 and $25. Raymond James initiated its price target at $42.

Pacira BioSciences Inc (PCRX) stock is down -24.54% over the week and -31.00% over the past month. Its price is -37.58% year-to-date and -45.72% over the past year.


To reach the target analysts have set, the stock logically needs to grow 49.99 percent from here.

The company has a return on investment of 4.84% and return on equity of 8.49%. The price to earnings ratio (P/E ratio) amounts to 15.12 while the forward price to earnings ratio is 5.87. The beta has a value of 0.88. Price to book ratio is 1.10 and price to sales ratio is 1.44.